Charu Agrawal MD
Hospice & Palliative Medicine
Oncologic Palliative Care Physician at the Dan L Duncan Comprehensive Cancer Center
Join to View Full Profile
7200 Cambridge StHouston, TX 77030
Phone+1 713-798-3750
Fax+1 713-798-4693
Dr. Agrawal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Hospice and Palliative Medicine, 2017
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2013 - 2016
Texas A&M; Health Science Center College of MedicineClass of 2013
Certifications & Licensure
TX State Medical License 2017 - 2025
DC State Medical License 2013 - 2016
VA State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hospice and Palliative Medicine
Publications & Presentations
PubMed
- 132 citationsTransmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections.Timothy Farinholt, Harsha Doddapaneni, Xiang Qin, Vipin Kumar Menon, Qingchang Meng
BMC Medicine. 2021-10-01 - 14 citationsTransmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infectionsTimothy Farinholt, Harshavardhan Doddapaneni, Xiang Qin, Vipin Kumar Menon, Qingchang Meng
Medrxiv. 2021-07-04 - 1 citationsMother Tongue.Charu Agrawal, Daniel Epner
JAMA Oncology. 2017-11-01
Lectures
- Dynamic monitoring of circulating tumor DNA next-generation gene sequencing as a predictive biomarker of response and progression-free survival after pembrolizumab mon...2019 ASCO Annual Meeting - 6/1/2019
- New Targets: Time To Get Excited?2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- A phase 1b/2a, multi-center, open-label study to evaluate the safety and efficacy of combination treatment with MEDI0457 (INO-3112) and durvalumab (MEDI4736) in patien...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
Best of Momentum in 2020December 31st, 2020- Cancer and Cannabis: What Patients Need to KnowSeptember 9th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
